Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries.
Identifieur interne : 000627 ( Main/Exploration ); précédent : 000626; suivant : 000628Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries.
Auteurs : Ben Davis [France] ; Joel Ladner ; Kelley Sams ; Ebru Tekinturhan ; Donald De Korte ; Joseph SabaSource :
- Malaria journal [ 1475-2875 ] ; 2013.
Descripteurs français
- KwdFr :
- MESH :
- traitement médicamenteux : Paludisme.
- usage thérapeutique : Artémisinines.
- Accessibilité des services de santé, Afrique, Association de médicaments, Enquêtes et questionnaires, Entretiens comme sujet, Humains, Pharmacies, Secteur privé, Évaluation de programme.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Artemisinins.
- geographic : Africa.
- drug therapy : Malaria.
- methods : Drug Therapy, Combination.
- Health Services Accessibility, Humans, Interviews as Topic, Pharmacies, Private Sector, Program Evaluation, Surveys and Questionnaires.
Abstract
In 2009, the Global Fund to Fight AIDS, Tuberculosis and Malaria established the Affordable Medicines Facility-malaria (AMFm) in order to increase access to quality-assured artemisinin combination therapy (QAACT). AMFm Phase 1, which includes nine pilot programmes in eight countries, was launched in 2009. The objective of this study was to assess anti-malarial stock and purchase patterns at private outlets in five AMFm Phase 1 countries in regard to three of the core AMFm goals: increase the affordability of QAACT, increase the availability of QAACT, and crowd out artemisinin monotherapies and other substandard therapies.
DOI: 10.1186/1475-2875-12-135
PubMed: 23607504
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000804
- to stream PubMed, to step Curation: 000804
- to stream PubMed, to step Checkpoint: 000804
- to stream Ncbi, to step Merge: 000557
- to stream Ncbi, to step Curation: 000557
- to stream Ncbi, to step Checkpoint: 000557
- to stream Main, to step Merge: 000628
- to stream Main, to step Curation: 000627
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries.</title><author><name sortKey="Davis, Ben" sort="Davis, Ben" uniqKey="Davis B" first="Ben" last="Davis">Ben Davis</name><affiliation wicri:level="3"><nlm:affiliation>Axios International, 7, Boulevard de Madeleine, Paris, 75001, France. joseph.saba@axiosint.com</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Axios International, 7, Boulevard de Madeleine, Paris, 75001</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region></placeName></affiliation></author><author><name sortKey="Ladner, Joel" sort="Ladner, Joel" uniqKey="Ladner J" first="Joel" last="Ladner">Joel Ladner</name></author><author><name sortKey="Sams, Kelley" sort="Sams, Kelley" uniqKey="Sams K" first="Kelley" last="Sams">Kelley Sams</name></author><author><name sortKey="Tekinturhan, Ebru" sort="Tekinturhan, Ebru" uniqKey="Tekinturhan E" first="Ebru" last="Tekinturhan">Ebru Tekinturhan</name></author><author><name sortKey="De Korte, Donald" sort="De Korte, Donald" uniqKey="De Korte D" first="Donald" last="De Korte">Donald De Korte</name></author><author><name sortKey="Saba, Joseph" sort="Saba, Joseph" uniqKey="Saba J" first="Joseph" last="Saba">Joseph Saba</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23607504</idno><idno type="pmid">23607504</idno><idno type="doi">10.1186/1475-2875-12-135</idno><idno type="wicri:Area/PubMed/Corpus">000804</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000804</idno><idno type="wicri:Area/PubMed/Curation">000804</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000804</idno><idno type="wicri:Area/PubMed/Checkpoint">000804</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000804</idno><idno type="wicri:Area/Ncbi/Merge">000557</idno><idno type="wicri:Area/Ncbi/Curation">000557</idno><idno type="wicri:Area/Ncbi/Checkpoint">000557</idno><idno type="wicri:Area/Main/Merge">000628</idno><idno type="wicri:Area/Main/Curation">000627</idno><idno type="wicri:Area/Main/Exploration">000627</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries.</title><author><name sortKey="Davis, Ben" sort="Davis, Ben" uniqKey="Davis B" first="Ben" last="Davis">Ben Davis</name><affiliation wicri:level="3"><nlm:affiliation>Axios International, 7, Boulevard de Madeleine, Paris, 75001, France. joseph.saba@axiosint.com</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Axios International, 7, Boulevard de Madeleine, Paris, 75001</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region></placeName></affiliation></author><author><name sortKey="Ladner, Joel" sort="Ladner, Joel" uniqKey="Ladner J" first="Joel" last="Ladner">Joel Ladner</name></author><author><name sortKey="Sams, Kelley" sort="Sams, Kelley" uniqKey="Sams K" first="Kelley" last="Sams">Kelley Sams</name></author><author><name sortKey="Tekinturhan, Ebru" sort="Tekinturhan, Ebru" uniqKey="Tekinturhan E" first="Ebru" last="Tekinturhan">Ebru Tekinturhan</name></author><author><name sortKey="De Korte, Donald" sort="De Korte, Donald" uniqKey="De Korte D" first="Donald" last="De Korte">Donald De Korte</name></author><author><name sortKey="Saba, Joseph" sort="Saba, Joseph" uniqKey="Saba J" first="Joseph" last="Saba">Joseph Saba</name></author></analytic><series><title level="j">Malaria journal</title><idno type="eISSN">1475-2875</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Africa</term><term>Artemisinins (therapeutic use)</term><term>Drug Therapy, Combination (methods)</term><term>Health Services Accessibility</term><term>Humans</term><term>Interviews as Topic</term><term>Malaria (drug therapy)</term><term>Pharmacies</term><term>Private Sector</term><term>Program Evaluation</term><term>Surveys and Questionnaires</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Accessibilité des services de santé</term><term>Afrique</term><term>Artémisinines (usage thérapeutique)</term><term>Association de médicaments ()</term><term>Enquêtes et questionnaires</term><term>Entretiens comme sujet</term><term>Humains</term><term>Paludisme (traitement médicamenteux)</term><term>Pharmacies</term><term>Secteur privé</term><term>Évaluation de programme</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Artemisinins</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Africa</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Malaria</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Drug Therapy, Combination</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Paludisme</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Artémisinines</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Health Services Accessibility</term><term>Humans</term><term>Interviews as Topic</term><term>Pharmacies</term><term>Private Sector</term><term>Program Evaluation</term><term>Surveys and Questionnaires</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Accessibilité des services de santé</term><term>Afrique</term><term>Association de médicaments</term><term>Enquêtes et questionnaires</term><term>Entretiens comme sujet</term><term>Humains</term><term>Pharmacies</term><term>Secteur privé</term><term>Évaluation de programme</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In 2009, the Global Fund to Fight AIDS, Tuberculosis and Malaria established the Affordable Medicines Facility-malaria (AMFm) in order to increase access to quality-assured artemisinin combination therapy (QAACT). AMFm Phase 1, which includes nine pilot programmes in eight countries, was launched in 2009. The objective of this study was to assess anti-malarial stock and purchase patterns at private outlets in five AMFm Phase 1 countries in regard to three of the core AMFm goals: increase the affordability of QAACT, increase the availability of QAACT, and crowd out artemisinin monotherapies and other substandard therapies.</div></front></TEI><affiliations><list><country><li>France</li></country><region><li>Île-de-France</li></region></list><tree><noCountry><name sortKey="De Korte, Donald" sort="De Korte, Donald" uniqKey="De Korte D" first="Donald" last="De Korte">Donald De Korte</name><name sortKey="Ladner, Joel" sort="Ladner, Joel" uniqKey="Ladner J" first="Joel" last="Ladner">Joel Ladner</name><name sortKey="Saba, Joseph" sort="Saba, Joseph" uniqKey="Saba J" first="Joseph" last="Saba">Joseph Saba</name><name sortKey="Sams, Kelley" sort="Sams, Kelley" uniqKey="Sams K" first="Kelley" last="Sams">Kelley Sams</name><name sortKey="Tekinturhan, Ebru" sort="Tekinturhan, Ebru" uniqKey="Tekinturhan E" first="Ebru" last="Tekinturhan">Ebru Tekinturhan</name></noCountry><country name="France"><region name="Île-de-France"><name sortKey="Davis, Ben" sort="Davis, Ben" uniqKey="Davis B" first="Ben" last="Davis">Ben Davis</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000627 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000627 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:23607504
|texte= Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23607504" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |